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Spinophilin is a protein phosphatase 1 (PP1)- and ac-
tin-binding protein that modulates excitatory synaptic
transmission and dendritic spine morphology. We re-
port that spinophilin is phosphorylated in vitro by pro-
tein kinase A (PKA). Phosphorylation of spinophilin was
stimulated by treatment of neostriatal neurons with a
dopamine D1 receptor agonist or with forskolin, consist-
ent with spinophilin being a substrate for PKA in intact
cells. Using tryptic phosphopeptide mapping, site-di-
rected mutagenesis, and microsequencing analysis, we
identified two major sites of phosphorylation, Ser-94
and Ser-177, that are located within the actin-binding
domain of spinophilin. Phosphorylation of spinophilin
by PKA modulated the association between spinophilin
and the actin cytoskeleton. Following subcellular frac-
tionation, unphosphorylated spinophilin was enriched
in the postsynaptic density, whereas a pool of phospho-
rylated spinophilin was found in the cytosol. F-actin
co-sedimentation and overlay analysis revealed that
phosphorylation of spinophilin reduced the stoichiome-
try of the spinophilin-actin interaction. In contrast, the
ability of spinophilin to bind to PP1 remained un-
changed. Taken together, our studies suggest that phos-
phorylation of spinophilin by PKA modulates the an-
choring of the spinophilin-PP1 complex within
dendritic spines, thereby likely contributing to the effi-
cacy and plasticity of synaptic transmission.
Dendritic spines are specialized protrusions that receive the
majority of excitatory input in the central nervous system
(1–3). Spines are highly motile and have been observed to
change shape rapidly in response to changes in behavior, hor-
monal status, and synaptic activity (4–12). This dynamic be-
havior is believed to be fundamental to the function of dendritic
spines and to contribute to the efficacy and plasticity of synap-
tic transmission. The ability of dendritic spines to change
shape has been attributed to a dense network of proteins that
facilitates the rapid assembly and disassembly of the actin
cytoskeleton (13, 14). Indeed, dendritic spines contain a rich
variety of receptors, ion channels, actin-regulating proteins,
and other biochemical machinery that support the organization
of the actin cytoskeleton (15, 16). Despite growing evidence
that this protein network may be involved in the dynamic
behavior of spines, the molecular mechanisms that underlie
this process are not well understood.
Spinophilin (also known as neurabin II) is a PP11- and actin-
binding protein that is enriched in dendritic spines (17, 18).
Several independent lines of evidence suggest that spinophilin
may link synaptic transmission to changes in the structure and
function of dendritic spines. Spinophilin has been shown to
regulate excitatory synaptic transmission by targeting PP1 to
-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid
(AMPA)- and N-methyl-D-aspartate (NMDA)-type glutamate
channels and promoting channel down-regulation through de-
phosphorylation (19, 20). Moreover, spinophilin-deficient mice
exhibited more persistent AMPA- and NMDA-receptor cur-
rents and greatly reduced long term depression (19).
Spinophilin is likely to influence the dynamic behavior of
dendritic spines by its ability to modulate the actin cytoskele-
ton. Spinophilin has been shown to bind and cross-link actin
filaments in vitro (18). In vivo, spinophilin-deficient mice ex-
hibited a marked increase in spine density during development
(19). Moreover, cultured neurons from spinophilin knockout
mice had more filopodia, or spine-like protrusions, but the
same number of nerve terminals as wild-type mice. These
observations suggest that spinophilin may either facilitate
spine retraction or suppress the initial outgrowth of spines
from the dendrite.
In addition to actin, spinophilin interacts with a variety of
other proteins, including its homologue neurabin (21, 22), D2-
class dopamine receptors (23), 2-adrenergic receptors (24),
and p70 S6 kinase (25). Thus, spinophilin may function as a
scaffold protein to regulate cross-talk between various physio-
logical stimuli in dendritic spines. However, it remains to be
determined whether spinophilin is regulated by specific neuro-
transmitter systems in the brain. Notably, spinophilin contains
consensus sequences for phosphorylation by several protein
kinases, including protein kinase A (PKA), Ca2/calmodulin-
dependent protein kinase II (CaMKII), and protein kinase C. In
the present study, we demonstrate that spinophilin is phospho-
rylated in vitro, and likely, in vivo, by PKA, and we have
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studied the functional consequences of spinophilin phosphoryl-
ation on its interactions with actin and PP1.
EXPERIMENTAL PROCEDURES
Materials—Male Sprague-Dawley rats (150–200 g) were obtained
from Charles River Laboratories (Wilmington, MA). Drugs were ob-
tained from the following sources: cyclosporin A, okadaic acid, and
calyculin A from Alexis Biochemicals (San Diego, CA); forskolin, SKF-
81297 and quinpirole from Sigma-Aldrich (St. Louis, MO). The purified
catalytic subunit of PP1 was kindly provided by Dr. Hsien-bin Huang
(National Chung Cheng University, Taiwan). Radioisotopes were pur-
chased from PerkinElmer Life Sciences (Boston, MA), and cellulose
thin-layer chromatography plates were from Kodak (Rochester, NY).
Restriction enzymes were purchased from Invitrogen (Rockville, MD)
and polyvinylidene difluoride (PVDF) membrane was from Millipore
(Bedford, MA). Oligonucleotides were obtained from Operon Technolo-
gies (Berkeley, CA), and peptides and phosphopeptides were synthe-
sized at The Rockefeller University Protein/DNA Technology Center
(New York, NY).
Preparation and 32P Labeling of Neostriatal Slices—Neostriatal
slices were prepared from male Sprague-Dawley rats (8–12 weeks old)
as described previously (26). Coronal sections (500 m in thickness)
were cut on a Vibratome (Ted Pella, Redding, CA), maintained at 4 °C,
and placed in cold, oxygenated (95% O2/5% CO2) Krebs-HCO3
 buffer
(125 mM NaCl, 5 mM KCl, 26 mM NaHCO3, 1.5 mM CaCl2, 1.5 mM
MgSO4, and 10 mM glucose, pH 7.4). Neostriatal slices were dissected
from the coronal sections under a dissecting microscope and transferred
individually to 2 ml of cold, oxygenated buffer. After replacing the
buffer with fresh Krebs-HCO3
 buffer, slices were preincubated at 30 °C
under constant oxygenation. After 30 min, the buffer was replaced with
fresh Krebs-HCO3
 buffer containing 2.0 mCi of [32P]orthophosphoric
acid, and the tissue was incubated for 60 min. The radioactive buffer
was then removed, and the slices were rinsed twice with 2 ml of fresh
buffer. The tissue was incubated in the absence or presence of forskolin
(50 M in Krebs-HCO3
 buffer) for 5 min. After treatment, the slices
were immediately frozen in liquid nitrogen and stored at 80 °C until
assayed.
Immunoprecipitation of 32P-Labeled Spinophilin—Frozen tissue
slices were sonicated in lysis buffer (10 mM Na2HPO4, pH 7.0, 150 mM
NaCl, 5 mM EDTA, 1% Triton X-100, and 0.2% SDS) containing prote-
ase inhibitors (1 mM phenylmethylsulfonyl fluoride, 20 g/ml leupeptin,
20 g/ml antipain, 5 g/ml pepstatin, 5 g/ml chymostatin, 1 mM
benzamidine) and phosphatase inhibitors (20 mM NaF, 1 mM Na3VO4,
0.05 mM Na2MoO4). The total [
32P]phosphate incorporated into trichlo-
roacetic acid-precipitated protein was determined for each sample, and
homogenates containing equal amounts of 32P-labeled proteins were
mixed with pre-swollen protein A-Sepharose CL-4B (10 l per sample,
Amersham Biosciences, Piscataway, NJ) for 1 h at 4 °C. The beads were
then pelleted by centrifugation, and the supernatant was transferred to
tubes containing a rabbit polyclonal antibody against spinophilin (3 g
of RU145 per sample (17)). The sample was mixed at 4 °C overnight and
then for an additional 2 h with pre-swollen protein A-Sepharose. The
beads were pelleted by centrifugation and washed four times with lysis
buffer and once with 50 mM HEPES, pH 7.0. After the final wash, the
beads were resuspended in SDS-PAGE sample buffer (50 mM Tris-HCl,
pH 6.7, 10% glycerol, 2% SDS, 10% 2-mercaptoethanol, and 0.01%
bromphenol blue), boiled for 5 min, and centrifuged. The recovered
proteins were resolved by SDS-PAGE on 8% acrylamide gels. The gels
were dried, and [32P]phosphate incorporation into spinophilin was vi-
sualized using a PhosphorImager 400B and ImageQuaNT software
from Amersham Biosciences.
Cloning and Expression of Spinophilin Fusion Proteins—A spinophi-
lin construct containing an amino-terminal histidine tag was prepared
as follows: the spinophilin sequence encoding residues 1–305 was am-
plified by PCR using the primers 5-CCC ACA TAT GAT GAA GAC
GGA GCC TCG-3 and 5-CTT TCC TCA ACC TCC ACC GGT T-3. The
resulting 900-bp fragment was digested with NdeI/XhoI and subcloned
with a XhoI/XhoI fragment of spinophilin (residues 220–817 (17)) into
the NdeI/XhoI site of the vector pET-15b (Novagen, Madison, WI). Point
mutations were introduced using the QuikChange site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA) and the spinophilin histidine
tag construct as a template. The actin-binding construct of spinophilin
encoding residues 1–221 was amplified by PCR using the primers
5-CCC ACA TAT GAT GAA GAC GGA GCC TCG-3 and 5-CGC GGA
TCC TAC CTC GAG TCG GCT TTC TCG A-3. The resulting fragment
was digested with NdeI/BamHI and ligated in-frame into the NdeI/
BamHI site of the vector pET-15b. All mutants were confirmed by
sequencing. Recombinant proteins were expressed in bacteria and pu-
rified using nickel-nitrilotriacetic acid agarose resin (Ni-NTA; Qiagen,
Valencia, CA) as described previously (27).
In Vitro Phosphorylation Reactions—Phosphorylation reactions were
performed using the protein of interest (10 M) and the catalytic sub-
unit of PKA (40 g/ml (28)) in 50 mM HEPES, pH 7.4, 10 mM MgCl2, 1
mM EGTA at 30 °C. Reactions were initiated by the addition of ATP (50
M) in the presence of [-32P]ATP. The reaction was terminated at
various time points by dilution of the reaction mixture into SDS-PAGE
sample buffer, and the stoichiometry of phosphorylation (moles of Pi/
mole of protein) was assessed after SDS-PAGE and autoradiography, by
measurement of 32P incorporation and normalization to the amount of
protein used.
Phosphopeptide Mapping—After autoradiography, gel pieces con-
taining 32P-labeled spinophilin were re-swollen in destain (50% meth-
anol/10% acetic acid in water), washed twice with 50% methanol in
water, and dried. Gel pieces were then incubated with L-1-tosylamido-
2-phenylethyl chloromethyl ketone-treated trypsin (50 g/ml, Worth-
ington, Lakewood, NJ) in 50 mM NH4HCO3, pH 8.0 (1 ml), for 18 h at
37 °C. The supernatants containing the soluble phosphopeptides were
recovered after centrifugation. The extraction efficiency (85%) was
quantified by Cerenkov counting of the gel pieces and supernatants
before and after digestion. Two-dimensional phosphopeptide mapping
was performed as described previously (29). For phosphopeptide map-
ping, electrophoretic separation was at pH 3.5 for 90 min at 400 V, and
ascending chromatography was in pyridine/n-butanol/acetic acid/water
(15:10:3:12). The pattern of tryptic phosphopeptides was detected by
autoradiography using PerkinElmer Life Sciences (Boston, MA) or
Kodak (Rochester, NY) film.
Identification of the Phosphorylation Sites on Spinophilin—Wild-
type and alanine mutant histidine fusion proteins were expressed in
BL21(DE3) Escherichia coli by the induction of log-phase cells (5-ml
cultures) with isopropyl-1-thio--D-galactopyranoside at 37 °C. After
1 h, cells were resuspended in ice-cold buffer (50 mM NaH2PO4, 300 mM
NaCl, 10 mM imidazole, pH 8.0, containing protease inhibitors) and
lysed by sonication. The lysate was centrifuged at 12,000  g for 5 min
at 4 °C, and the supernatant was mixed with Ni-NTA resin (20 l per
sample) for 30 min at 4 °C. The resin was washed three times with
ice-cold buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH
8.0) and once with 50 mM HEPES, pH 7.4, 10 mM MgCl2. Phosphoryl-
ation reactions were carried out as described above with the proteins
bound to the resin. After 1 h, reactions were terminated with SDS-
PAGE sample buffer, and the phosphorylated proteins were loaded onto
8% acrylamide gels for autoradiography and phosphopeptide mapping
analysis.
Phosphorylation sites, determined by point mutations, were con-
firmed by reverse phase capillary high performance liquid chromatog-
raphy (HPLC) and microsequencing analysis. Wild-type spinophilin (10
g) was phosphorylated by PKA in the presence of [-32P]ATP. The
reaction mixture was separated by SDS-PAGE and electrophoretically
transferred to a PVDF membrane. The 32P-labeled spinophilin was
localized by autoradiography, and the membrane was excised and sub-
jected to proteolytic digestion with trypsin or GluC proteases. Eluted
peptides were separated by HPLC, and fractions eluting from the cap-
illary column were spotted directly onto a strip of PVDF membrane
using a 153 microblotter (PerkinElmer Life Sciences, Boston, MA (30)).
Membrane pieces containing the 32P-labeled phosphopeptides were ex-
cised and subjected to automated amino-terminal protein microse-
quencing and mass spectrometry.
Generation of Phosphorylation State-specific Antibodies—Rabbit
polyclonal phosphorylation state-specific antibodies were generated
and purified essentially as described (31). Antibodies were raised
against the following cysteine-containing phosphopeptides conjugated
to thyroglobulin: VRL(pS)LPRAC (residues 91–98), CLPRAS(pS)LNE
(residues 95–103), and CQERA(pS)LQDRK (residues 173–182). Affinity
purification was performed using dephospho- and phosphopeptides cou-
pled to SulfoLink gel (Pierce, Rockford, IL).
Treatment of Neostriatal Slices and Immunoblotting—Neostriatal
slices were dissected as described above and preincubated in fresh
Krebs-HCO3
 buffer at 30 °C under constant oxygenation. After 30 min,
the slices were incubated in Krebs-HCO3
 buffer in the absence or
presence of the indicated drugs for 5–60 min. The slices were then
frozen in liquid nitrogen and stored at 80 °C until assayed. Frozen
tissue samples were sonicated in boiling 1% SDS containing protein
phosphatase and protease inhibitors. The protein concentrations of the
homogenates were determined using the BCA protein assay method
(Pierce, Rockford, IL) with bovine serum albumin as a standard. Equal
amounts of protein (100 g) were separated by SDS-PAGE using 6%
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acrylamide gels and transferred to PVDF membranes (0.2 m). Mem-
branes were blocked for 1 h in TBS (50 mM Tris-HCl, 150 mM NaCl, pH
7.4) containing 5% (w/v) nonfat dry milk and 0.1% Tween 20 and then
incubated with rabbit polyclonal antibodies against spinophilin, phos-
pho-Ser-94 spinophilin, phospho-Ser-100 spinophilin, or phospho-Ser-
177 spinophilin. Following washes with TBS containing 1% nonfat
milk, 0.1% Tween 20, and 0.5% bovine serum albumin, proteins were
visualized by incubation with anti-rabbit horseradish peroxidase-con-
jugated secondary antibodies (1:5000 dilution, Pierce, Rockford, IL) and
enhanced chemiluminescence (ECL) development (Amersham Bio-
sciences, Piscataway, NJ). Chemiluminescence was detected by expo-
sure of blots to photographic film, and bands were quantified by anal-
ysis of scanned images using Image 1.52 software (National Institutes
of Health). Because the linear range for quantification of signal density
by the ECL detection method is limited to 10-fold, we routinely ex-
posed chemiluminescent membranes to film for various time periods to
obtain signals within the linear range. Data were analyzed by the
Mann-Whitney U test, with significance defined as p  0.05.
Phosphorylation of Spinophilin in HEK 293T Cells and Cultured
Neurons—Embryonic day 17 rat cerebrocortical or striatal tissue was
used to prepare primary cortical and striatal cultures as described (32,
33). Full-length spinophilin was transiently expressed in 293T cells for
36 h following calcium phosphate transfection. Cells were treated with
forskolin (50 M) for 5 min and lysed in 1% SDS containing protease
inhibitors and phosphatase inhibitors. Equal amounts of total protein
were resolved on 6% acrylamide gels and analyzed by immunoblotting.
Actin Purification and Iodination—Actin was prepared from an ac-
etone powder of rabbit skeletal muscle in buffer A (0.2 mM CaCl2, 0.2
mM ATP, 0.5 mM NaN3, 0.5 mM 2-mercaptoethanol, 2 mM Tris-HCl, pH
8.0) as described (34) and further purified by gel filtration on a Seph-
adex G-150 column (35). G-actin was polymerized in buffer A containing
2 mM MgCl2/90 mM KCl. Polymerized actin was labeled with Na
125I (5
mCi per 2 mg of actin) using IODO-BEADs (Pierce, Rockford, IL).
125I-Labeled actin was purified over a desalting column (D-salt, Pierce,
Rockford, IL) and eluted with 5 mM Tris-HCl, pH 8.0, 0.2 mM ATP, 0.2
mM CaCl2, 0.5 mM dithiothreitol.
F-actin Overlays—Protein samples were separated by SDS-PAGE
and transferred to nitrocellulose membranes (Schleicher & Schuell,
Keene, NH). Membranes were dried for 30 min and blocked in 10 mM
Tris-HCl, pH 7.4, 90 mM NaCl, 0.5% Tween 20 containing 5% nonfat dry
milk for 2 h at room temperature. Membranes were incubated with
125I-labeled actin (50 g/ml) in blocking buffer containing phalloidin (5
M, Cytoskeleton, Denver, CO) at room temperature without agitation.
After 2 h, the blots were briefly washed five times with 10 mM Tris-HCl,
pH 7.4, 90 mM NaCl, 0.5% Tween 20 and dried. Actin binding was
quantified using a PhosphorImager 400B and ImageQuaNT software.
An anti-His tag monoclonal antibody (Clontech, Palo Alto, CA) was used
to detect the amount of spinophilin in each sample, and immunoreac-
tive protein bands were quantified using 125I-labeled protein A and
PhosphorImager analysis.
PP1 Overlays—Protein samples were separated by SDS-PAGE and
transferred to PVDF membranes. Membranes were blocked for 1 h in
TBST (50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20, pH 7.4) con-
taining 5% nonfat milk, and then incubated with bacterially expressed
PP1 (1.5 g/ml) in 50 mM Tris-HCl, pH 7.0, 0.1 mM EGTA, 15 mM
2-mercaptoethanol, 0.01% brij-35, 0.3 mg/ml bovine serum albumin at
4 °C overnight. After washing twice with TBST containing 0.25% nonfat
milk, membranes were probed with an anti-PP1 antibody (1.5 g/ml in
TBST containing 1% nonfat milk (36)) for 1 h. Following several
washes, proteins were visualized by incubation with anti-rabbit horse-
radish peroxidase-conjugated secondary antibodies and ECL
development.
F-actin Sedimentation—Phosphorylation reactions were performed
on a large-scale using purified recombinant spinophilin (3 M,500 g)
and in the absence or presence of PKA (40–100 g/ml) in 50 mM
HEPES, pH 7.4, 10 mM MgCl2, 1 mM EGTA at 30 °C. Reactions were
initiated by the addition of ATP (50 M). An aliquot of the reaction
mixture was incubated in parallel with [-32P]ATP for determination of
the phosphorylation stoichiometry (1.6 mol/mol phosphorylated approx-
imately equally at Ser-94 and Ser-177). After 1 h, the reaction mixtures
were exhaustively dialyzed into 20 mM Tris-HCl, 50 mM NaCl, pH 7.4.
Immediately prior to the actin sedimentation experiments, proteins
were centrifuged at 200,000 g for 30 min. Protein concentrations were
determined using the BCA protein assay method with bovine serum
albumin as a standard.
The indicated amounts of spinophilin (62.5–1000 nM, 30 l) were
incubated with 1 M polymerized actin (0.1 nmol actin/sample, 70 l)
for 30 min at room temperature. The samples were centrifuged at
200,000  g for 30 min, and the pellet was resuspended in SDS-PAGE
sample buffer and loaded onto acrylamide gels. The pelleted actin was
stained with Coomassie Brilliant Blue R-250 and quantified by laser
scanning densitometry. The spinophilin associated with the actin pellet
was visualized by autoradiography after immunoblotting with an anti-
spinophilin antibody and 125I-labeled secondary antibodies and was
quantified by radioactive counting of the excised bands. Samples were
incubated in parallel with spinophilin (62.5–1000 nM) in the absence of
actin to correct for a small amount of pelleted spinophilin in the back-
ground. Standard curves of actin and spinophilin were constructed for
each analysis.
Subcellular Fractionation—The striatum of Sprague-Dawley rats
was homogenized in ice-cold 0.32 M sucrose, and subcellular fractions
were prepared as described (37). Proteins were resolved by SDS-PAGE
and transferred to PVDF membrane. Immunoblots were probed with
the indicated antibodies and visualized by ECL development.
RESULTS
Spinophilin Is Phosphorylated by PKA—The amino acid se-
quence of spinophilin contains consensus phosphorylation sites
for several protein kinases, including PKA, protein kinase C,
and Ca2/calmodulin-dependent protein kinases. To examine
whether spinophilin is regulated by phosphorylation in vivo,
striatal slices were labeled with [32P]orthophosphate, and spi-
nophilin was immunoprecipitated. A significant level of basal
phosphorylation of spinophilin was detected (Fig. 1A). More-
over, phosphorylation was increased following treatment with
the adenylyl cyclase activator, forskolin, suggesting that
spinophilin might be phosphorylated by PKA in vivo. Two-
dimensional phosphopeptide maps of spinophilin immunopre-
cipitated from 32P-labeled slices revealed multiple phospho-
peptides under basal conditions (Fig. 1C), as well as the
appearance of novel phosphopeptides upon treatment with for-
skolin (peptides labeled 1, 2, and 4, Fig. 1C).
To confirm that PKA directly phosphorylates spinophilin, we
performed phosphorylation reactions in vitro using recombi-
nant spinophilin, PKA, and [-32P]ATP. Phosphorylation pro-
ceeded in a time-dependent manner and reached a maximal
stoichiometry of 2.3 mol/mol within 60 min (Fig. 1B). The
initial rate of phosphorylation was comparable to that of inhib-
itor-1, a physiological substrate of PKA known to be phospho-
rylated at a single site. Two-dimensional phosphopeptide maps
of spinophilin phosphorylated by PKA to low (1-min incuba-
tion) or higher (60-min incubation) stoichiometry revealed the
presence of five major phosphopeptides (labeled 1–5, Fig. 1D).
The phosphopeptides phosphorylated in vitro by PKA corre-
sponded to the pattern of phosphopeptides phosphorylated in
spinophilin in slices in response to forskolin (Fig. 1C) (with the
exception that peptide 5 could not be detected in spinophilin
phosphorylated in slices). Together, these results support the
conclusion that PKA phosphorylates spinophilin in vivo at a
subset of the total sites phosphorylated in intact cells.
Identification of the PKA Phosphorylation Sites on Spinophi-
lin—Spinophilin contains multiple consensus sites for PKA
phosphorylation within its 817-amino acid sequence. No signif-
icant phosphorylation was detected using a truncated spinophi-
lin fragment consisting of amino acids 298–817 fused to glu-
tathione S-transferase. We therefore focused on a region at the
amino terminus of spinophilin (amino acids 1–221) that exhib-
its a high degree of homology with the actin-binding domain in
neurabin (18, 21). This region was phosphorylated as efficiently
as the full-length protein. Tryptic phosphopeptide maps of the
amino-terminal fragment exhibited the same five major phos-
phopeptides as were detected using wild-type spinophilin (Fig.
1E), indicating that all of the PKA phosphorylation sites are
located within the actin-binding domain of spinophilin.
As shown in Fig. 2A, the actin-binding domain contains nine
consensus sites for PKA phosphorylation. To identify specific
sites of phosphorylation, we compared the phosphopeptide map
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of wild-type spinophilin to maps of alanine mutants at each
putative serine phosphorylation site. Mutant proteins were
expressed as histidine fusion proteins in small-scale bacterial
cultures, purified using Ni-NTA agarose, and phosphorylated
with PKA and [-32P]ATP. Mutation of Ser-94 led to the specific
disappearance of phosphopeptides 1 and 2 (Fig. 2B, left panel);
mutation of Ser-100 removed phosphopeptide 3 from the maps
(Fig. 2B, middle panel), and mutation of Ser-177 eliminated
phosphopeptides 4 and 5 (Fig. 2B, right panel). The disappear-
ance of two phosphopeptides upon mutation of a single serine/
threonine site has previously been observed (38) and most
likely results from multiple tryptic cleavage sites. Interest-
ingly, the phosphopeptide map of the Ser-94 mutant showed
increased phosphorylation at Ser-100, suggesting that elimina-
tion of this primary site of phosphorylation enhances the phos-
phorylation kinetics of secondary sites. Mutation of all other
putative phosphorylation sites (Ser-17, Ser-59, Ser-87, Ser-99,
Ser-122, and Ser-126) had no effect on the phosphopeptide map
patterns (data not shown).
We confirmed the identity of the putative phosphorylation
sites by HPLC and microsequencing analysis. Recombinant
spinophilin was phosphorylated in vitro using PKA and
[-32P]ATP, and the tryptic phosphopeptides were purified by
HPLC. Microsequencing analysis of the radiolabeled peptides
identified two major peptides encompassing the Ser-94 and
Ser-100 sites (amino acids 93–97 and 98–111; Table I). A third,
weakly radiolabeled HPLC fraction was found to contain the
peptide 59–85. Peptide 59–85 has likely co-purified with a
phosphopeptide of low abundance (too low to sequence); how-
ever, we cannot rule out the possibility that this peptide con-
tains a minor phosphorylation site that was not detected by
phosphopeptide mapping. Although initial studies using the
TABLE I
Sequencing of phosphopeptides from spinophilin
phosphorylated by PKA
Phosphopeptides were obtained by proteolytic cleavage of phospho-
rylated spinophilin. Following HPLC purification, radiolabeled pep-
tides were identified by microsequencing and mass spectrometry. Res-
idues in parentheses were not identified with certainty. X corresponds
to phosphoserines (bold and underlined) or other residues that could not
be sequenced.
Peptide sequence Amino acids
Tryptic cleavage (L)XLPR 93–97
XXXLNENVDX(S)(A)X(L) 98–111
XMFLQM(G)TTTPP(G)EA. . . 59–85
Glu-C cleavage XAXLQDRKLDXV(V). . . 175–194
FIG. 1. Phosphorylation of spinophilin by PKA. A, spinophilin
was immunoprecipitated from 32P-labeled neostriatal slices treated
without or with forskolin. The incorporation of [32P]phosphate into
spinophilin was visualized by autoradiography. B, time course for the in
vitro phosphorylation of spinophilin by PKA, with comparison to inhib-
itor-1. Proteins were phosphorylated in vitro using PKA and
[-32P]ATP. The stoichiometry of phosphorylation was assessed after
SDS-PAGE and autoradiography. C, phosphopeptide maps of spinophi-
lin immunoprecipitated from neostriatal slices incubated without (basal
slice) or with forskolin (forskolin-treated slice). Proteins were excised
from gels as shown in panel A and digested with trypsin. The resultant
phosphopeptides were separated by two-dimensional phosphopeptide
mapping and visualized by autoradiography. D, phosphopeptide maps
of spinophilin phosphorylated for 60 min (left panel) or 1 min (right
panel). The autoradiograms were exposed for different times to give
approximately equivalent intensities of the phosphopeptides. E, phos-
phopeptide map of the actin-binding domain of spinophilin (residues
1–221). For D and E, proteins were phosphorylated in vitro with PKA
and [-32P]ATP and analyzed by SDS-PAGE and two-dimensional phos-
phopeptide mapping. Peptides were labeled 1–5 based on the pattern
observed for full-length spinophilin phosphorylated by PKA in vitro,
with the number just to the right of the relevant phosphopeptide. In the
peptide maps obtained from spinophilin phosphorylated in intact cells,
peptide 5 was not consistently detected.
FIG. 2. Identification of the PKA phosphorylation sites on spi-
nophilin. A, the actin-binding domain of spinophilin contains nine
consensus sites for PKA phosphorylation (underlined). The identified
sites of phosphorylation (Ser-94, Ser-100, and Ser-177) are boxed. B,
two-dimensional phosphopeptide maps of alanine mutants of spinophi-
lin (S94A, S100A, S177A).
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protease trypsin did not identify a peptide encompassing Ser-
177, digestion with the protease Glu-C produced a phosphopep-
tide that could be resolved by HPLC and identified as amino
acids 175–194. Together with the phosphopeptide mapping
studies, these results indicate that Ser-94 and Ser-177 of spi-
nophilin are phosphorylated efficiently by PKA at comparable
rates. In contrast, Ser-100 of spinophilin is phosphorylated by
PKA at a significantly lower rate.
Phosphorylation of Ser-94 and Ser-177 of Spinophilin in
Intact Cells—Having established the primary sites of phospho-
rylation in vitro, we generated phosphorylation state-specific
antibodies to the Ser-94, Ser-100, and Ser-177 sites to analyze
the phosphorylation of spinophilin in greater detail. The anti-
phospho-Ser-94, anti-phospho-Ser-100 and anti-phospho-Ser-
177 antibodies recognized spinophilin only upon phosphoryla-
tion by PKA; no detectable binding to dephosphorylated
spinophilin was observed (Fig. 3A). Importantly, each antibody
did not cross-react with the other phosphorylated site of spi-
nophilin (Fig. 3B). The anti-phospho-Ser-177 antibody failed to
detect phosphorylated spinophilin upon mutation of Ser-177
(but not of Ser-94) to alanine. Similarly, mutation of Ser-94 to
alanine prevented anti-phospho-Ser-94, from detecting phos-
phorylated spinophilin. Because Ser-100 is also a putative
substrate site for CaMKII, we examined the possible phospho-
rylation of spinophilin by CaMKII. Indeed, CaMKII phospho-
rylated Ser-100 of spinophilin. However, the physiological sig-
nificance of this in vitro phosphorylation is presently unknown.
We then used the phospho-specific antibodies to examine the
phosphorylation of spinophilin in both transfected HEK 293T
cells and in cultured neurons. In either cell type, very low basal
phosphorylation of Ser-94 and Ser-177 was observed, whereas
activation of PKA with forskolin (50 M) significantly increased
the phosphorylation at both sites (Fig. 4A). In contrast, 1,9-
dideoxy forskolin, an inactive form of forskolin, had no effect on
spinophilin phosphorylation under similar conditions (data not
shown). Unlike Ser-94 and Ser-177, basal phosphorylation of
Ser-100 appeared to be higher in cultured neurons, and incu-
bation with forskolin had little effect (Fig. 4B).
Involvement of a D1 Receptor/cAMP Cascade in Regulation of
Phosphorylation of Spinophilin in Neurons—To understand
further the regulation and functional significance of spinophi-
lin phosphorylation in the brain, we identified signaling path-
ways that modulate spinophilin phosphorylation in the neos-
triatum. Rat neostriatal slices were incubated with various
pharmacological agents, and the phosphorylation of spinophi-
lin was monitored by immunoblotting of cell lysates. Because
dopamine is known to stimulate adenylyl cyclase activity in the
neostriatum, we evaluated the potential contribution of the two
major classes of dopamine receptors, D1 and D2, on spinophilin
phosphorylation. The D1 class receptors stimulate adenylyl
FIG. 3. Specificity of the phosphorylation state specific anti-
bodies. A, spinophilin was phosphorylated in vitro without (dephos) or
with PKA (PKA phos) or with CaMKII (CaMKII phos) as indicated, and
phosphorylation state-specific antibodies to phospho-Ser-94, phospho-
Ser-100, or phospho-Ser-177 were used to detect phosphorylated spi-
nophilin by immunoblotting. B, the antibodies displayed no cross-reac-
tivity toward other phosphorylated sites of spinophilin. Wild-type (WT)
spinophilin and mutants in which Ser-94 (S94A), Ser-100 (S100A), or
Ser-177 (S177A) were replaced with alanine were phosphorylated in
vitro without (dephos) or with PKA or CaMKII (phos) as indicated.
Proteins were resolved by SDS-PAGE and transferred to PVDF mem-
branes. Samples were analyzed by immunoblotting with the phospho-
Ser-94, phospho-Ser-100, or phospho-Ser-177 antibodies as indicated.
FIG. 4. Spinophilin is phosphorylated in response to activa-
tion of PKA at Ser-94 and Ser-177 in HEK 293T cells and cul-
tured neurons. A and B, 293T cells, transiently transfected with
spinophilin, or cultured neurons were incubated in the absence (basal)
or presence of forskolin (50 M) for 5 min. Proteins were resolved by
SDS-PAGE and transferred to PVDF membranes. Spinophilin was de-
tected by immunoblotting with the indicated antibodies.
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cyclase and increase cAMP formation (41), whereas D2 class
receptors are coupled to multiple effector systems, including
adenylyl cyclase, Ca2 and K channels, and phospholipase C
(42). Treatment of neostriatal slices with the D1 receptor ago-
nist SKF81297 increased the phosphorylation of both Ser-94
(133  17% of control) and Ser-177 (236  2% of control),
whereas the D2 receptor agonist quinpirole had no effect on
basal phosphorylation levels (Fig. 5A). As expected, forskolin
stimulation significantly increased the phosphorylation of both
Ser-94 (440 20% compared with control) and Ser-177 (1030
46% of control; Fig. 5A). These results strongly suggest that
dopamine stimulates the phosphorylation of spinophilin via
activation of a D1 receptor/PKA pathway.
We next examined the role of serine/threonine protein phos-
phatases in regulating spinophilin dephosphorylation. Neo-
striatal slices were incubated with cyclosporin A, a selective
protein phosphatase-2B inhibitor, or with calyculin A or oka-
daic acid, both inhibitors of PP1 and protein phosphatase-2A
(PP2A). Calyculin A, which has previously been shown to in-
hibit both PP1 and PP2A activity in neostriatal slices by 40%
(1 M (43)), increased the phosphorylation of Ser-94 and Ser-
177 by 5.8- and 4.4-fold, respectively (584  78% and 439 
75% of control; Fig. 5B). Smaller, but significant, increases of
3.3- and 1.9-fold (332  13% and 185  6% of control), respec-
tively, were produced with okadaic acid at concentrations that
inhibit PP2A activity by 80% and PP1 activity by 5% (200 nM
(43)). In contrast, treatment with cyclosporin A resulted in
no detectable changes in basal phosphorylation levels (102 
16% for Ser-94 and 95  28% for Ser-177 of control). These
FIG. 5. Regulation of spinophilin phosphorylation in the neos-
triatum. A, effect of forskolin, the D1 receptor agonist SKF81297 and
the D2 receptor agonist quinpirole on the phosphorylation of spinophi-
lin. Neostriatal slices were incubated with forskolin (50 M), SKF81297
(1 M), or quinpirole (1 M) for 5 min. B, effect of phosphatase inhibitors
on the phosphorylation of spinophilin. Neostriatal slices were incubated
with calyculin A (200 nM), okadaic acid (1 M), or cyclosporin A (5 M)
for 60 min. For both A and B, the homogenates were subjected to
SDS-PAGE and immunoblotted with the indicated phospho-specific
antibodies. The amount of phosphorylated spinophilin was quantified
by densitometry, and the data were normalized to the values obtained
with untreated slices. Data represent means  S.E. for three or four
experiments. *, p  0.05; Mann-Whitney U test compared with control.
FIG. 6. Phosphorylated spinophilin is localized to discrete sub-
cellular compartments. Rat neostriatal homogenates were fraction-
ated as described under “Experimental Procedures,” and the subcellu-
lar fractions were analyzed by immunoblotting with the indicated
antibodies. 25 g of total protein was loaded in each lane, with the
exception of the PSD fractions, which contained 15 g. As expected,
NMDA receptor immunoreactivity was enriched in the PSD fractions.
FIG. 7. Phosphorylation disrupts
the interaction of spinophilin with
actin filaments but not with PP1. Spi-
nophilin was phosphorylated in vitro to
various stoichiometries and examined for
its ability to bind (A) actin filaments or
(D) PP1. An anti-histidine tag antibody
was used to detect total spinophilin lev-
els. B, the phosphorylation stoichiometry
and extent of actin binding were quanti-
fied using a PhosphorImager 400B and
ImageQuaNT software. The values for ac-
tin binding represent the fraction of the
total amount of actin bound at time zero.
Data represent means  S.E. for three
experiments. C, the relative rates of phos-
phorylation of Ser-177 and Ser-94 were
determined by immunoblotting aliquots
of samples of spinophilin phosphorylated
at different times.
Phosphorylation Modulates Spinophilin Function 1191
data suggest that PP1, and possibly also PP2A, can reverse
the PKA-mediated phosphorylation of spinophilin in the
neostriatum.
Phosphorylated Spinophilin Is Enriched in Specific Subcel-
lular Compartments—We compared the subcellular distribu-
tions of phosphorylated and unphosphorylated spinophilin by
immunoblotting with anti-spinophilin, anti-phospho-Ser-94, or
anti-phospho-Ser-177 antibodies. As a control, the various sub-
cellular fractions were also probed with an antibody selective
for the NMDA receptor NR1 subunit, which is enriched in
postsynaptic densities. Spinophilin was found in both cytosolic
and membrane-associated fractions of rat neostriatum and was
highly concentrated in the PSD (Fig. 6). A single extraction
(Triton X-100) of the PSD pellet did not remove spinophilin,
suggesting that a significant fraction of spinophilin is tightly
associated with the PSD. Similar to other targeting proteins
localized to dendritic spines (44), further extraction with Sar-
kosyl detergent disrupted the interaction of spinophilin with
the PSD.
The phosphorylated forms of spinophilin showed striking
localization to specific subcellular compartments. Spinophilin
phosphorylated at Ser-94 was concentrated in membrane frac-
tions, including the PSD. In contrast, spinophilin phosphoryl-
ated at Ser-177 was absent from the PSD, although it remained
associated with both the P3 and synaptic plasma membrane
fraction. Importantly, spinophilin phosphorylated at Ser-177
was highly enriched in the cytosolic S3 fraction. These findings
suggest that phosphorylation of spinophilin at Ser-177 reduces
the ability of spinophilin to interact with one or more specific
proteins in the postsynaptic density. Because phosphorylated
spinophilin remains associated to some extent with the synap-
tic membrane, our data suggest that phosphorylation does not
induce large movements in the localization of spinophilin;
rather it may trigger subtle alterations in the targeting of
spinophilin within dendritic spines.
The differential distributions of phospho-Ser-94 and phos-
pho-Ser-177 spinophilin suggest that phosphorylation at each
site may be differentially regulated in vivo. The phosphoryla-
tion studies in slices support this notion, because the Ser-177
site appeared to be more responsive to activation of PKA (10-
fold versus 4.5-fold) than the Ser-94 site, but both sites were
approximately equally responsive to inhibition of PP1/PP2A
with calyculin A (Fig. 5). The greater phosphorylation of Ser-
177 may reflect the different pools of PP1 and PP2A that are
present in these subcellular fractions, in particular the fact
that PP1 is enriched in the PSD fraction (45). Thus, the delicate
balance of kinase and phosphatase activities in neurons may
regulate the steady-state levels of phosphorylation at each site,
thereby controlling the targeting of spinophilin within den-
dritic spines.
Phosphorylation of Spinophilin Reduces Its Interaction with
Actin Filaments—Because the two major PKA phosphorylation
sites of spinophilin, Ser-94 and Ser-177, are located within the
actin binding region, we examined whether phosphorylation
might influence the interaction between spinophilin and the
actin cytoskeleton. Spinophilin was phosphorylated in vitro to
various stoichiometries and examined for its ability to bind
actin filaments using a 125I-labeled F-actin overlay assay. Un-
der these conditions, the stoichiometries of phosphorylation of
Ser-94 and Ser-177 were approximately equal at all time points
as determined by either phosphopeptide mapping (see Fig. 1D
above) or by the use of the phospho-specific antibodies to the
two sites (Fig. 7C). F-actin binding decreased in parallel to the
increase in the level of spinophilin phosphorylation, reaching a
maximum reduction of 70% observed at a sub-maximal stoi-
chiometry of 1.2 mol/mol (Fig. 7, A and B). These results
suggest that phosphorylation by PKA directly disrupts the
association between spinophilin and F-actin.
We further analyzed the interaction of phosphorylated spi-
nophilin with actin filaments by performing co-sedimentation
studies. Spinophilin was phosphorylated by PKA to a stoichi-
ometry of 1.6 mol/mol and incubated with polymerized actin.
For comparison, unphosphorylated spinophilin was analyzed in
parallel. Following ultracentrifugation, the amount of spi-
nophilin associated with the actin pellet was measured by
quantitative immunoblotting (Fig. 8). The analysis of the bind-
ing isotherms indicated that phosphorylation did not alter the
binding affinity of spinophilin for F-actin: dephospho- and
phospho-spinophilin exhibited similar dissociation constants of
455  88 and 490  35 nM, respectively. These values are close
to the Kd of 500 nM previously reported for dephospho-spinophi-
lin (18). In contrast, the stoichiometry of the spinophilin-actin
FIG. 8. Phosphorylation decreases the stoichiometry of the
spinophilin-actin interaction. A, polymerized actin (1 M) was in-
cubated with the indicated amounts of dephosphorylated or phospho-
rylated spinophilin (phosphorylated to 1.6 mol/mol). Following ultra-
centrifugation, the amount of spinophilin associated with the actin
pellet was measured by quantitative immunoblotting. B and C, binding
isotherms (B) indicate that phosphorylation markedly decreases the
binding stoichiometry (Bmax) without affecting the dissociation constant
(Kd) of the spinophilin-actin interaction (C). Data represent means 
S.E. for three experiments.
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interaction decreased by 53% upon phosphorylation (Bmax of
12  0.7 mol/mol for dephospho-spinophilin, 5.7  0.8 mol/mol
for phospho-spinophilin, p  0.003). Phosphorylation of spi-
nophilin did not appear to perturb the G- to F-actin equilibrium
(data not shown), consistent with the binding of spinophilin to
the sides rather than the ends of actin filaments (18).
In addition to associating with actin, spinophilin binds to
PP1 and inhibits its activity in vitro. We therefore investigated
whether phosphorylation might modulate the interaction of
spinophilin with PP1. Phosphorylation of spinophilin by PKA,
however, had no detectable effect on PP1 binding in overlay
assays (Fig. 7D). Taken together, these results strongly suggest
that the phosphorylation of spinophilin by PKA regulates its
association with the actin cytoskeleton, without disrupting the
spinophilin-PP1 complex.
DISCUSSION
We have provided the first demonstration that protein ki-
nases modulate the function of spinophilin in neurons. Our
data indicate that spinophilin is phosphorylated by PKA in
vitro at Ser-94 and Ser-177, which are located within the actin-
binding domain of spinophilin. Ser-94 and Ser-177 are con-
tained within consensus sites for phosphorylation by PKA and
are phosphorylated in neurons in response to activation of D1
dopamine receptors or forskolin, consistent with both sites
being physiological targets for PKA in intact cells. Ser-100 was
identified as a minor site for PKA in vitro but was not regulated
by activation of PKA in vivo. Interestingly, Ser-94 and Ser-177
of spinophilin are not conserved in neurabin, a homologue of
spinophilin that shares 48% amino acid identity with spi-
nophilin. This observation suggests that the functional activi-
ties of spinophilin and neurabin may be differentially regulated
through protein phosphorylation. Indeed, neurabin is phospho-
rylated in vitro by PKA at a specific site that is not found in
spinophilin, and phosphorylation appears to decrease the asso-
ciation of neurabin with PP1 (46).
Phosphorylation of spinophilin by PKA disrupts its ability to
associate with actin filaments. Interestingly, phosphorylated
spinophilin bound to F-actin with high affinity, but with re-
duced stoichiometry. These findings suggest that the actin
binding region of spinophilin contains at least two distinct
recognition sites for actin. In support of this idea, we have
observed that the actin-binding domain of spinophilin (amino
acids 1–221) is sufficient to bundle actin filaments.2 Phospho-
rylation of spinophilin may disrupt one of these sites, reducing
the number of actin molecules bound to spinophilin without
perturbing the binding affinity of spinophilin for F-actin. Sev-
eral actin bundling proteins, including -actinin, dystrophin,
and spectrin, possess multiple actin-binding domains, which
contact actin molecules via -helical structures (47–49). Under
the conditions used in the present study, both Ser-94 and
Ser-177 were phosphorylated to approximately equal levels.
Ser-94 and Ser-177 reside in regions predicted to adopt -hel-
ices, and phosphorylation of spinophilin at either or both sites
may prevent the binding of actin molecules through destabili-
zation of the protein-protein interface.
Phosphorylation of spinophilin was associated with de-
creased binding to the post-synaptic density. In contrast to
unphosphorylated spinophilin, spinophilin phosphorylated at
Ser-177 was absent from the PSD and was enriched in the
cytosolic fractions. This striking difference in subcellular local-
ization suggests that phosphorylation triggers changes in the
targeting of spinophilin within dendritic spines. Although it is
possible that the pool of spinophilin associated with the PSD
cannot be phosphorylated by PKA, we consider this possibility
unlikely. Several protein kinase A anchoring proteins have
been shown to target PKA to the PSD (50, 51) and enable the
kinase to phosphorylate proteins such as the GluR1 subunit of
AMPA receptors (26), NMDA channels (52, 53), and other re-
ceptors. Moreover, phosphorylation of spinophilin at the Ser-94
site was shown to occur in the PSD. Taken together with our
actin-binding studies, the altered subcellular distribution of
phosphorylated spinophilin supports the notion that PKA acti-
vation dynamically modulates the localization of spinophilin
within dendritic spines.
Our previous studies have shown in striatal neurons that
spinophilin plays a role in the regulation of AMPA channels by
the dopamine D1 receptor/cAMP/DARPP-32 cascade (19, 20).
This is believed to result from an amplification process that
involves both direct phosphorylation of the channel by PKA
and inhibition of PP1 activity via PKA-mediated phosphoryla-
tion of DARPP-32. In these studies, we also observed that
AMPA currents were stabilized by perfusion into neurons of a
synthetic spinophilin peptide that disrupts the targeting of PP1
to spinophilin (20). This latter result implicated spinophilin in
the localized targeting of active PP1 close to AMPA channels.
In the present study, we have found that phosphorylation by
PKA perturbed the interaction of actin with spinophilin, but
that it had no effect on the binding of PP1 to spinophilin. Thus,
activation of cAMP-dependent signaling would be expected to
alter the association of the spinophilin-PP1 complex with the
actin cytoskeleton. Phosphorylation of spinophilin by PKA may
therefore contribute to the increased phosphorylation of AMPA
channels by also altering the localization of PP1 (Fig. 9).2 L. C. Hsieh-Wilson and P. Greengard, unpublished observations.
FIG. 9. Model for the regulation of AMPA-type glutamate receptors by spinophilin. Spinophilin anchors PP1 in the vicinity of the AMPA
channel by binding to actin filaments. Under basal conditions, the spinophilin-PP1 complex maintains the AMPA channel in a dephosphorylated
state in which it is relatively insensitive to its neurotransmitter, glutamate. After D1 receptor stimulation, AMPA channel phosphorylation is
increased due to phosphorylation of spinophilin by PKA, likely targeted close to the synapse via protein kinase A-anchoring proteins. In turn, the
spinophilin-PP1 complex is removed from the vicinity of the channel and leads to synergistic increases in phosphorylation of the AMPA receptor.
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The ability of cAMP-dependent signaling cascades to alter
dynamically the localization of the spinophilin-PP1 complex
may also have important consequences for synaptic plasticity.
PP1 has been found to play a role in synaptic plasticity likely by
modulating AMPA type glutamate channels important for syn-
aptic transmission, and targeting of PP1 has been proposed to
play a role in long term depression (54, 55). Spinophilin knock-
out mice exhibit altered glutamatergic transmission and re-
duced long term depression (19), suggesting that spinophilin is
responsible for the regulation of AMPA receptors by PP1. Phos-
phorylation of spinophilin by PKA may contribute to regulation
of ion channel conductances critical for the maintenance and
plasticity of dendritic spines (56, 57). Phosphorylation of spi-
nophilin may also influence trafficking of AMPA receptors by
modulating the actin cytoskeleton in dendritic spines.
Spinophilin phosphorylation could have other important con-
sequences for the structure and function of dendritic spines.
Changes in the number, size, and shape of dendritic spines
have been associated with learning, electrophysiological, devel-
opmental, and hormonal changes (4–12). The ability of den-
dritic spines to change shape has been attributed to a dense
network of proteins that facilitates the rapid assembly and
disassembly of the actin cytoskeleton (13, 14). Spinophilin has
been shown to cross-link actin filaments in vitro and to regu-
late the development of dendritic spines in vivo (19). Thus,
phosphorylation of spinophilin may influence the morphology
of spines by modulating the bundling or polymerization of actin
filaments. Alternatively, phosphorylation may serve to control
PP1-mediated changes in the actin cytoskeleton. Previous stud-
ies have shown that PP1 regulates cellular morphology
through dephosphorylation of the actin cytoskeleton (58–60).
In conclusion, we have demonstrated that phosphorylation of
spinophilin is increased in response to dopamine D1 receptor/
cAMP signaling cascades. Spinophilin phosphorylation, in
turn, modulates its ability to interact with the actin cytoskel-
eton. Our findings suggest that phosphorylation of spinophilin
by PKA regulates anchoring of the spinophilin-PP1 complex
within dendritic spines. These studies may provide greater
insight into the molecular mechanisms that underlie synaptic
plasticity and dendritic spine morphology. Future studies will
examine the dynamic targeting of the spinophilin-PP1 complex
in living neurons and its impact on the structure and function
of dendritic spines.
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